Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2024

11.09.2023

Timing of cryoballoon pulmonary vein isolation to prevent atrial fibrillation recurrence

verfasst von: Giuseppe Stabile, Roberto Verlato, Giuseppe Arena, Paolo Pieragnoli, Claudio Tondo, Giulio Molon, Massimiliano Manfrin, Giovan Battista Perego, Giovanni Rovaris, Luigi Sciarra, Massimo Mantica, Riccardo Sacchi, Daniele Nicolis, Saverio Iacopino

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The aims of this analysis were: to evaluate the impact of timing of ablation on the rate of atrial arrhythmias recurrence, verify if the timing of ablation impact differently in patients with paroxysmal and persistent AF.

Methods

Three thousand two hundred and five patients (60.5 ± 10 years, female 28.4%%, 78.8%% paroxysmal AF) were included in the analysis. All patients underwent only cryoballoon (CB) pulmonary vein (PV) isolation during the index procedure.

Results

The mean procedure time was 102.8 ± 50 min, with a mean fluoroscopy time of 26.3 ± 49 min. Acute PV isolation was achieved in 11760/11793 (99.7%) PVs. A total of 91 (2.8%) patients experienced a procedure-related complication. During the observation period 913/3205 (28.5%) patients had at least one atrial arrhythmias episode: 28% of patients with paroxysmal AF vs 33% of patients with persistent AF. In multivariate analysis, persistent AF together with time from symptomatic AF diagnosis to ablation, female sex, and ablation time showed to be significant predictors for AF recurrence. In particular, months from first symptomatic AF episode > 18 months was a significant predictor of AF recurrence (HR = 1.23, 95% CI = 1.03—1.46, p = 0.020).
In patients with paroxysmal AF, the multivariate analysis confirmed that months from first symptomatic AF episode > 18 month was an independent predictor of AF recurrence together with age > 62 years and female sex. In patients with persistent AF, the time from persistent AF showed to be significant predictor for AF recurrence.

Conclusions

In this multicenter analysis, time from first symptomatic AF episode > 18 months was a significant predictor of AF recurrence after CB PV isolation.
Literatur
1.
Zurück zum Zitat Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, ESC Scientific Document Group, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.CrossRefPubMed Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, ESC Scientific Document Group, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.CrossRefPubMed
2.
Zurück zum Zitat Imberti JF, Ding WY, Kotalczyk A, Zhang J, Boriani G, Lip G, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107:1630–6.CrossRefPubMed Imberti JF, Ding WY, Kotalczyk A, Zhang J, Boriani G, Lip G, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107:1630–6.CrossRefPubMed
3.
Zurück zum Zitat Pallisgaard JL, Gislason GH, Hansen J, Johannessen A, Torp-Pedersen C, Rasmussen PV, et al. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J. 2018;39:442–9.CrossRefPubMed Pallisgaard JL, Gislason GH, Hansen J, Johannessen A, Torp-Pedersen C, Rasmussen PV, et al. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J. 2018;39:442–9.CrossRefPubMed
4.
Zurück zum Zitat Stabile G, Trines SA, Arbelo E, Dagres N, Brugada J, Kautzner J, et al. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA atrial fibrillation ablation long-term Registry. Pacing Clin Electrophysiol. 2019;42:313–20.CrossRefPubMed Stabile G, Trines SA, Arbelo E, Dagres N, Brugada J, Kautzner J, et al. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA atrial fibrillation ablation long-term Registry. Pacing Clin Electrophysiol. 2019;42:313–20.CrossRefPubMed
5.
Zurück zum Zitat Solimene F, Giannotti Santoro M, Stabile G, Malacrida M, De Simone A, et al. Early rhythm-control ablation therapy to prevent atrial fibrillation recurrences: Insights from the CHARISMA Registry. Pacing Clin Electrophysiol. 2021;44:2031–40.CrossRefPubMed Solimene F, Giannotti Santoro M, Stabile G, Malacrida M, De Simone A, et al. Early rhythm-control ablation therapy to prevent atrial fibrillation recurrences: Insights from the CHARISMA Registry. Pacing Clin Electrophysiol. 2021;44:2031–40.CrossRefPubMed
6.
Zurück zum Zitat Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, et al. Pulmonary vein isolation with the cryoballoon technique: feasibility, procedural outcomes, and adoption in the real world: data from one shot technologies to pulmonary vein isolation (1STOP) project. Pacing Clin Electrophysiol. 2017;40:46–56.CrossRefPubMed Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, et al. Pulmonary vein isolation with the cryoballoon technique: feasibility, procedural outcomes, and adoption in the real world: data from one shot technologies to pulmonary vein isolation (1STOP) project. Pacing Clin Electrophysiol. 2017;40:46–56.CrossRefPubMed
7.
Zurück zum Zitat Stabile G, Iacopino S, Verlato R, Arena G, Pieragnoli P, Molon G, et al. Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation. Europace. 2020;22:1798–804.CrossRefPubMed Stabile G, Iacopino S, Verlato R, Arena G, Pieragnoli P, Molon G, et al. Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation. Europace. 2020;22:1798–804.CrossRefPubMed
8.
Zurück zum Zitat Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA, Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–68.CrossRefPubMed Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA, Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–68.CrossRefPubMed
9.
Zurück zum Zitat Kirchof P, Camm AJ, Goette A, Brandes A, Eckart L, Elvan A, EAST-AFNET 4 Trial Investigators, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383:1305–16.CrossRef Kirchof P, Camm AJ, Goette A, Brandes A, Eckart L, Elvan A, EAST-AFNET 4 Trial Investigators, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383:1305–16.CrossRef
10.
Zurück zum Zitat Andrade J, Khairy P, Dobrev D, Nattel S. The Clinical profile and pathophysiology of atrial fibrillation: relationships among clinicalfeatures, epidemiology, and mechanism. Circ Res. 2014;114:1453–68.CrossRefPubMed Andrade J, Khairy P, Dobrev D, Nattel S. The Clinical profile and pathophysiology of atrial fibrillation: relationships among clinicalfeatures, epidemiology, and mechanism. Circ Res. 2014;114:1453–68.CrossRefPubMed
11.
Zurück zum Zitat Baysal E, Okşul M, Burak C, Yalin K, Soysal AU, Yalman H, et al. Decreasing time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation positively affects long-term consequences. J Interv Card Electrophysiol. 2022;65:365–72.CrossRefPubMed Baysal E, Okşul M, Burak C, Yalin K, Soysal AU, Yalman H, et al. Decreasing time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation positively affects long-term consequences. J Interv Card Electrophysiol. 2022;65:365–72.CrossRefPubMed
12.
Zurück zum Zitat Lunati M, Arena G, Iacopino S, Verlato R, Tondo C, Curnis A, et al. Is the time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation a predictor of efficacy? J Cardiovasc Med (Hagerstown). 2018;19(8):446–52.CrossRefPubMed Lunati M, Arena G, Iacopino S, Verlato R, Tondo C, Curnis A, et al. Is the time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation a predictor of efficacy? J Cardiovasc Med (Hagerstown). 2018;19(8):446–52.CrossRefPubMed
14.
Zurück zum Zitat Andrade JC, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, EARLY-AF Investigators, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023;388:105–13.CrossRefPubMed Andrade JC, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, EARLY-AF Investigators, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023;388:105–13.CrossRefPubMed
Metadaten
Titel
Timing of cryoballoon pulmonary vein isolation to prevent atrial fibrillation recurrence
verfasst von
Giuseppe Stabile
Roberto Verlato
Giuseppe Arena
Paolo Pieragnoli
Claudio Tondo
Giulio Molon
Massimiliano Manfrin
Giovan Battista Perego
Giovanni Rovaris
Luigi Sciarra
Massimo Mantica
Riccardo Sacchi
Daniele Nicolis
Saverio Iacopino
Publikationsdatum
11.09.2023
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2024
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-023-01636-3

Weitere Artikel der Ausgabe 3/2024

Journal of Interventional Cardiac Electrophysiology 3/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.